Sleep Hygiene Education, ReadiWatchTM Actigraphy and Telehealth Cognitive Behavioral Training for Insomnia for Symptom Relief in Men with Prostate Cancer Receiving Androgen Deprivation Therapy, SHERE-Relief 2 Trial
This clinical trial evaluates the effectiveness of wearing a ReadiWatch, trademark, actigraphy for sleep hygiene education and telehealth cognitive behavioral training for insomnia (teleCBT-I) to improve symptoms of insomnia in men with prostate cancer receiving androgen deprivation therapy. Many treatments, such as androgen deprivation therapy, for prostate cancer can cause significant fatigue and/or problems with memory and concentration and can also result in disturbed sleep. Improving sleep may reduce feelings of fatigue and improve memory and concentration. The ReadiWatch is a wearable device that provides real-time feedback on sleep patterns, instructions on how to improve sleep, and a score that indicates periods of time when fatigue and issues with memory and concentration may be troublesome. Behavioral interventions, such as teleCBT-I, use techniques to help patients change the way they react to environmental triggers that may cause a negative reaction. A ReadiWatch together with teleCBT-I may improve sleep and quality of life in men with prostate cancer receiving androgen deprivation therapy.